|This article needs additional citations for verification. (May 2012) (Learn how and when to remove this template message)|
|Traded as||FWB: SRT|
|Industry||Pharmaceutical and Laboratory Equipment|
|Founded||1870 in Göttingen|
|Joachim Kreuzburg (CEO and chairman of the Executive Board), Reinhard Vogt (Member of the Executive Board),
Jörg Pfirrmann (Member of the Executive Board)
|Revenue||€ 891.2 million (2014)|
Number of employees
The Sartorius group is an international pharmaceutical and laboratory equipment supplier, covering the segments of Bioprocess Solutions and Lab Products & Services.
In 2014, the technology group earned sales revenue of 891.2 million euros (2013: 791.6). Founded in 1870, the Göttingen-based company currently employs around 5,600 persons.
The company consists of the two divisions 'Bioprocess Solutions' and 'Lab Products & Services'. Bioprocess Solutions includes the segments filtration, fluid management, fermentation and purification and focuses on the production processes of the biopharmaceutical industry. Lab Products & Services focuses on the production and servicing of laboratory instruments and consumables. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and commercial agencies in more than 110 countries. The Sartorius preference share has been traded at the German technology index TecDAX since 18 June 2012.
Within the Management Board, Reinhard Vogt is responsible for Marketing, Sales and Services, while Jörg Pfirrmann manages Finance, IT, General Administration and Human Resources as well as being Executive for Labor Relations. The CEO, Joachim Kreuzburg, is responsible for Corporate Strategy, Legal, Compliance as well as Communications. He also is Chairman of the Board and CEO of the subgroup Sartorius Stedim Biotech .
140 years ago in 1870 Florenz Sartorius (1846–1925) a Göttingen University Mechanician founded the fine precision weighing company called "Feinmechanische Werkstatt F. Sartorius" and began with the production of short-beam analytical balances. The new light weight material aluminum he used to produce these ensured rapid overseas sales.
To allow the use of hydro power the company moved north of Göttingen to Bovenden, the new factory provided work for 60 people. This move coincided with the production of the 3000th scale by the company in 1895. However, in 1899 the headquarters of the company was to move once more, this time to a plot near the Weender highway on the northern outskirts of Göttingen.
In 1906, the founder's three sons William (1872–1937), Erich (1876–1947) and Julius (1878–1918) became partners in their father's company. Shortly after in 1911, the company celebrated the construction of its 10,000th analytical balance. In 1914, Florenz and his sons turned the company into a stock corporation to expand its capital base.
During the First World War the company was converted into producing military hardware, and the successful foreign business wings of the company were broken off. After the war ended, the company returned to the proven business of weighing technology; however, it was not until the mid-1930s that the pre-war production figures were once again achieved.
With the start of the Second World War, the company was once again taken over for the purpose of building military hardware, this time for the air force, and for this purpose a new factory was completed in 1941.
Between the wars in 1927, the company under the name Membranfiltergesellschaft m.b.H. began the industrial production of membrane filters, an area of production developed from the Nobel prize winner Richard Zsigmondy and his associate Wilhelm Bachmann. This early phase of production is still the foundation for Sartorius’ bioprocess business which is used in the production of filters today.
Acquisitions (since 2000)
Sartorius takes over B. Braun Biotech International (BBI) from the B. Braun Melsungen AG . BBI, the world's leading manufacturer of fermenters (bioreactor) and cell culture systems at the time, is integrated into the Sartorius group as Sartorius Stedim Systems GmbH (formerly Sartorius BBI Systems GmbH ), a subsidiary of Sartorius Stedim Biotech GmbH .
Sartorius AG acquires the remaining shares in Viva Science and is now the sole owner.
Sartorius acquires 100% of the shares of Omnimark Instrument Corporation, Arizona, USA (moisture analyzers).
Sartorius merges its biotechnology division with the French biotech company 'Stedim S.A.'. The resulting Sartorius Stedim Biotech is the world's leading technology provider for the biopharmaceutical industry. The new company is listed on the Paris stock exchange.
Sartorius takes over the Toha Plast GmbH , which now operates under the name Sartorius Stedim Plastics .
Through its subgroup Sartorius Stedim Biotech Sartorius acquires the Swiss-based Wave Biotech AG, a leading provider of single-use bioreactors.
Sartorius acquires the liquid handling business of the Finnish laboratory specialists Biohit . Thus, the Group expands its product portfolio in the field of laboratory instruments.
Sartorius expands its bioprocess portfolio by cell culture media and enters a long-term cooperation agreement with the Swiss Life Science Group Lonza.
Through its subgroup Sartorius Stedim Biotech Sartorius acquires the British firm TAP Biosystems Group plc; Expansion of bioprocess portfolio in fermentation.
Through its subgroup Sartorius Stedim Biotech Sartorius acquires a majority stake in the US start-up AllPure Technologies LLC, thus complementing the disposables portfolio for the biopharmaceutical industry.
The company acquired cell-based assay and instrumentation firm Essen BioScience, from private equity owner SFW Capital Partners, for $320 million.
In December 2014, Sartorius sells the division Industrial Technologies, a specialist in industrial weighing and control equipment, to the Japanese company Minebea Co., Ltd. Consequently, Sartorius concentrates on its core businesses bioprocess and laboratory. The operational structure of the Group therefore consists of the two divisions Bioprocess Solutions and Lab Products & Services.
In April 2015, Sartorius through its subgroup Sartorius Stedim Biotech (SSB) acquires the Scottish company BioOutsource Ltd., thus integrating bioanalytical testing services into the portfolio.
In July 2015, Sartorius through its subgroup Sartorius Stedim Biotech (SSB) acquires the Laupheim-based company Cellca, thus further expanding its service offering for process development.
In 2001, Sartorius receive the "Innovation Award of the German Economy" for its development of the GENIUS analytical balance. Two years later Sartorius competed for and received the "Initiative Prize" for training and continuing education from the Otto Wolf foundation, the German Chamber of Commerce and industry and the German-language weekly financial journal Wochenmagazin.
In 2004, the company received the Frost & Sullivan award for its innovation in product differentiation technology. In 2005 Sartorius won the "Best innovator of 2005" from the category of ‘Time to profit" awarded by the international management consultant A.T.Hearney and German business magazine Wirtschaftswoche.
In 2006, the international consulting company Frost and Sullivan awarded Sartorius the "2006 Growth Strategy Leadership Award".
In 2012, Sartorius won the reddot design award for its new electronic pipette "Picus".
In 2016, the Sartorius marketing campaign #passionforscience was nominated on the Shortlist (Top 5) for the Marketing Intelligence and Innovations Awards (MIIA) 2016 in the category Multi-Channel Strategy.
- Sartorius Annual Report 2014
- Press Release: Sartorius moves up to the TecDAX
- Sartorius Chronicle
- Press Release: Sartorius to Sell Its Industrial Technologies Division to Minebea Co., Ltd.
- Press Release: Sartorius Stedim Biotech acquires UK-based CRO, BioOutsource
- Press Release: Sartorius Stedim Biotech acquires Cellca
- Sartorius History
- Product website Picus
- "MIIA Awards 2016". Marketing Intelligence and Innovation Awards 2016. Quadriga Media Berlin GmbH. Retrieved 5 October 2016.